施罗德人增加了32.5%的Illuma持有量,尽管Q4收入激增和EPS失灵。 Schroders increased Illumina holdings by 32.5%, despite Q4 revenue surge and EPS miss.

在Q4中,DF Dent & Co.和CalPERS减少了他们在Illumina的股份,而Schroder投资管理公司增加了32.5%的股份,购买了48 263股。 In Q4, DF Dent & Co. and CalPERS reduced their stakes in Illumina, while Schroder Investment Management increased its holdings by 32.5%, buying 48,263 shares. 基因分析公司Illumina报告收入猛增70.7%,但未计入EPS的估计数0.06美元。 Illumina, a genetic analysis company, reported a 720.7% revenue jump but missed EPS estimates by $0.06. 股票市场上限为129.7亿美元,协商一致价格目标为140.90美元。 The stock has a market cap of $12.97 billion, with a consensus price target of $140.90.